Denali Therapeutics
DNLI
#4389
Rank
A$2.82 B
Marketcap
$19.48
Share price
-7.90%
Change (1 day)
-32.41%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -$1.56

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.74. In 2022 the company made an earnings per share (EPS) of -$4.30 a decrease over its 2021 EPS that were of -$3.95.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.56-63.76%
2022-$4.308.79%
2021-$3.95-712.82%
2020$0.65-118.93%
2019-$3.41402.44%
2018-$0.68-88.89%
2017-$6.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.08 77.14% Jersey
-$11.89 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.41 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.25 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK